Phibro Animal Health Corporation (PAHC)

The analysis of Phibro Animal Health Corporation’s days of sales outstanding (DSO) reveals relatively stable receivables collection periods over the specified period. As of June 30, 2021, the DSO was approximately 64.32 days, indicating that on average, the company took just over two months to collect receivables. This figure increased slightly to 64.51 days by June 30, 2022, demonstrating a marginal extension in the collection period, which could suggest either a slight delay in receivables collection or a change in credit terms or customer payment behavior.

In the subsequent year, the DSO decreased to 61.02 days as of June 30, 2023. This reduction indicates an improvement in receivables collection efficiency, possibly due to enhanced credit or collection policies, improved customer payment practices, or a shift in the customer base. The DSO further declined to 60.78 days by June 30, 2024, maintaining a level consistent with the previous year and suggesting a continued trend toward more efficient receivables management.

However, by June 30, 2025, the DSO increased again to 64.20 days, returning close to the levels observed in 2021 and 2022. This fluctuation could imply a temporary weakening in collection efficiency, changes in credit terms, or variations in customer payment cycles.

Overall, the DSO has exhibited minor fluctuations over the four-year span without indicating a definitive trend of deterioration or consistent improvement. The average collection period remains around 60 to 65 days, which is within typical industry ranges for companies in the animal health sector. These stability levels suggest that the company's receivables management has been relatively consistent over this period, with brief periods of slight improvement followed by marginal increases.

Peer comparison

Jun 30, 2025